An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Warren, Richard B.; Mrowietz, Ulrich; von Kiedrowski, Ralph; Niesmann, Johannes; Wilsmann-Theis, Dagmar; Ghoreschi, Kamran; Zschocke, Ina; Falk, Thomas M.; Bloedorn-Schlicht, Norbert; Reich, Kristian

dc.contributor.author	Ghoreschi, Kamran
dc.date.accessioned	2018-04-24T08:40:29Z
dc.date.available	2018-04-24T08:40:29Z
dc.date.issued	2017
dc.identifier.issn	1474-547X
dc.identifier.uri	http://hdl.handle.net/10900/81615
dc.language.iso	en	de_DE
dc.publisher	Elsevier Science Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/S0140-6736(16)32127-4
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01773
utue.publikation.seiten	528-537	de_DE
utue.personen.roh	Warren, Richard B.
utue.personen.roh	Mrowietz, Ulrich
utue.personen.roh	von Kiedrowski, Ralph
utue.personen.roh	Niesmann, Johannes
utue.personen.roh	Wilsmann-Theis, Dagmar
utue.personen.roh	Ghoreschi, Kamran
utue.personen.roh	Zschocke, Ina
utue.personen.roh	Falk, Thomas M.
utue.personen.roh	Bloedorn-Schlicht, Norbert
utue.personen.roh	Reich, Kristian
dcterms.isPartOf.ZSTitelID	Lancet	de_DE
dcterms.isPartOf.ZS-Issue	10068	de_DE
dcterms.isPartOf.ZS-Volume	389	de_DE
utue.fakultaet	04 Medizinische Fakultät